How $300 per Month Can Create $50,000 in Annual Dividend Income
Steadily building a portfolio of high-quality dividend payers could set you up for decades of passive income. Ideally, you'll ...
Pharmabiz17h
AbbVie’s Vyalev receives US FDA approval to treat adults living with advanced Parkinson's disease
AbbVie announced that the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the ...
AbbVie says latest FDA approval expands Botox use beyond face
Botox Cosmetic expands beyond face for the first time as FDA approves the anti-wrinkle therapy for treating platysma bands.
Allergan Aesthetics: FDA Approves BOTOX® Cosmetic For The Treatment Of Platysma Bands
Allergan Aesthetics, an AbbVie company (ABBV), announced that FDA approves BOTOX® Cosmetic for temporary improvement in the ...
emjreviews.com21h
24-Hour Therapy for Parkinson’s: The First Of Its Kind
The U.S. FDA has approved the first 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease.